Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is rated as an Elite provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Cameron has had a long and distinguished career in alimentary tract diseases and specifically in pancreatic cancer. He has won worldwide acclaim for mastering the Whipple procedure. At the beginning of his career, the mortality rate from the Whipple procedure was nearly 30 percent. He has worked to lower that to 1 percent to 2 percent at Johns Hopkins. He has operated on more patients with pancreatic cancer and done more Whipple resections than any other surgeon in the world. In addition to maintaining a busy practice that focuses mainly on pancreatic surgery, he has been a leader in the surgical profession, serving as president of the American College of Surgeons, Society for Surgery of the Alimentary Tract, Southern Surgical Association, Society of Clinical Surgery, Society of Surgical Chairmen, Halsted Society and American Surgical Association. He served as chief of surgery for The Johns Hopkins Hospital for nineteen years. Dr. Cameron obtained his undergraduate degree from Harvard University in 1958, and his medical degree from The Johns Hopkins University School of Medicine in 1962. All of his training in General and Thoracic Surgery was obtained at The Johns Hopkins Hospital. Dr. Cameron is rated as an Elite provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Christopher Shubert, M.D., M.H.A., is a general surgeon with specialty training and interests in hepato-pancreato-biliary (HPB) surgery. He is a member of the Division of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology at The Johns Hopkins Hospital. Dr. Shubert earned his medical degree from the University of Alabama School of Medicine and completed his general surgery residency at the Mayo Clinic in Rochester, Minnesota. He completed fellowship training in HPB surgical oncology and abdominal organ transplantation at the University of Toronto. In addition to his clinical experience, Dr. Shubert earned a Master's of Science in Healthcare Administration from the University of Alabama at Birmingham. Dr. Shubert's clinical interests include HPB surgery, resection of traditionally unresectable liver lesions, tumors involving the vena cava, and pancreas resections with vascular reconstruction. His research focus includes hepatobiliary and pancreatic malignancies, their respective treatments, perioperative management, and outcomes. Dr. Shubert is rated as a Distinguished provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy.

Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is rated as a Distinguished provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Dr. Elliot K. Fishman is a Professor in the Johns Hopkins Medicine Department Radiology and Radiological Science, Department of Oncology and Department of Surgery. He serves as a member of the Johns Hopkins Kimmel Cancer Center. His clinical and research interests focus on medical imaging with specific emphasis on three-dimensional (3D) imaging and computed tomography (CT). Dr. Fishman received his B.S. in 1973 and M.D. in 1977 from the University of Maryland. After a residency at Sinai Hospital in Baltimore, he completed a fellowship in CT at Johns Hopkins in 1980 and joined the Johns Hopkins faculty in 1981 as an Assistant Professor. In 1986, he became Associate Professor and, in 1991, Professor of Radiology and Oncology. He is a leader in the development of 3D imaging and rendering, including its impacts on and uses in patient care and management. He was involved from the beginning in the development of 3D imaging through his work with Pixar, which was a spin-off from LucasFilms in San Rafael, California. Over the last 25 years, Dr. Fishman continued to help develop 3D imaging and has been a leader in the development of interactive 3D rendering. His team is consistently at the forefront of research and development of new visualization and post-processing techniques and technologies. Dr. Fishman's extensive body of work in CT has resulted in over 1,000 peer-reviewed publications, and he is the author or co-author of 10 textbooks. He is the recipient of three prestigious Aunt Minnie Awards, honoring his outstanding contributions as both an educator and researcher. In 2007, he was named by Medical Imaging Magazine as the Top Radiologist in the Nation. He is a member of editorial boards for more than 35 journals, an active member of several professional radiology associations and is a past-president of the Society of Body CT/MR. Dr. Fishman is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Ductal Adenocarcinoma, Cavernous Lymphangioma, Pancreaticoduodenectomy, and Pancreatectomy.

Ana De Jesus is an Oncologist in Baltimore, Maryland. Dr. De Jesus is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Kelly Lafaro, MD, MPH, is a general surgeon with a specialty in gastrointestinal surgical oncology and hepatobiliary surgery. She is part of the Johns Hopkins Kimmel Cancer Center. Dr. Lafaro earned her medical degree from Tulane University School of Medicine and completed her residency at New York-Presbyterian/Columbia University Irving Medical Center. Her fellowship in complex general surgical oncology was completed at City of Hope National Medical Center. Dr. Lafaro’s expertise includes pancreatic adenocarcinoma, neuroendocrine tumors, minimally invasive pancreatic and liver surgeries, and colorectal liver metastases. In addition to her clinical experience, Dr. Lafaro is published in the field of liver and pancreatic cancer. She is interested in the improvement of surgical and post-surgical outcomes. Dr. Lafaro is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreatectomy, and Pancreaticoduodenectomy.

Gastroenterologist Mouen Khashab specializes in therapeutic endoscopy, and he oversees this group of practitioners across the Johns Hopkins enterprise. Nationally and internationally known in the field of interventional endoscopy, Dr. Khashab has contributed immensely to the field’s advancement as a minimally invasive means to treat gastrointestinal and pancreaticobiliary disorders. Dr. Khashab earned his medical degree from the American University of Beirut Faculty of Medicine, and subsequently completed a residency in internal medicine and a fellowship in gastroenterology at Indiana University. He then completed a two-year fellowship at The Johns Hopkins Hospital before joining the faculty in 2011. A busy researcher, Dr. Khashab has published more than 600 papers in peer-reviewed journals. In 2013, he described the procedure called gastric peroral endoscopic myotomy (known as G-POEM) and was able to disseminate and teach it all over the world. Other procedures that he expanded include peroral endoscopic myotomy (POEM), peroral endoscopic myotomy with fundoplication (POEM-F), Zenker’s peroral endoscopic myotomy (Z-POEM) and full thickness resection. In 2022, he received the Master Endoscopist Award from the American Society for Gastrointestinal Endoscopy (ASGE) for his numerous contributions to the field. His procedural expertise includes endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), interventional EUS, submucosal endoscopy, POEM/achalasia, endoscopic mucosal resection, endoscopic submucosal dissection, luminal stenting, large polyp resection and Barrett’s therapy, among others. Dr. Khashab is involved with multiple gastrointestinal societies and has served on many committees, including the ASGE Standards of Practice Committee, which is in charge of formulating guidelines for the practice of endoscopy. He has also served as an associate editor for the journal Endoscopy, a premier journal in the field. Khashab is a highly sought-after speaker at national and international conferences, and he has participated in multiple live endoscopy conferences. Outside of academic medicine, Dr. Khashab is an entrepreneur. His major interest is in new technology and medical devices, and his goal is to disrupt the field by introducing technology that makes endoscopic procedures safer, easier, efficient and more scalable. Dr. Khashab is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Achalasia, Pancreatic Pseudocyst, Bile Duct Obstruction, Endoscopy, and Gastric Bypass.

Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Atif Zaheer is a Professor of Radiology and Radiological science at Johns Hopkins University School of Medicine, as well as the director of the Cross-Sectional Body Imaging Fellowship program. Dr. Zaheer practices at the Johns Hopkins Hospital in Baltimore, MD. Dr. Zaheer earned his medical degree from the Aga Khan University. He completed a residency in diagnostic radiology at Beth Israel Deaconess Medical Center/Harvard Medical School, followed by a fellowship in abdominal imaging and interventional radiology at Brigham and Women’s Hospital/Harvard Medical School. Dr. Zaheer is also the medical director of the e-Radiology learning program at Johns Hopkins, which provides radiology residents and practicing radiologists around the world with a lecture series designed to address core knowledge of normal anatomy, pathology and background physics required for successful practice of the field. Dr. Zaheer is clinically active in cross-sectional imaging of the body using CT, MRI and Ultrasound and is also involved in multidisciplinary conferences for pancreas, liver and rectal cancer imaging. His research interests include imaging of tumors and inflammatory disorders of the pancreas and is considered a leader in pancreatic imaging. He is the associate editor of the journal Abdominal Radiology and actively participates in clinical trials, publishes scientific articles, authors books on pancreatic and gastrointestinal imaging, and gives talks at national and international conferences. Dr. Zaheer is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Muscle Invasive Bladder Cancer, Pancreatic Ductal Adenocarcinoma, Pancreas Divisum, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Narang is an Assistant Professor in the Johns Hopkins Department of Radiation Oncology & Molecular Sciences. A former chief resident in the department, Dr. Narang now specializes in radiation treatment for gastrointestinal malignancies, including pancreatic cancer, colorectal cancer, hepatobiliary malignancies, and gastric cancer. Dr. Narang has an interest in expanding multi-disciplinary care for patients with gastrointestinal malignancies. Make A Gift. Dr. Narang is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, Pancreaticoduodenectomy, and Pancreatectomy.

Vikesh Singh is a gastroenterologist who specializes in pancreatology and pancreaticobiliary endoscopy. He evaluates and treats patients with inflammatory diseases of the pancreas, including acute and chronic pancreatitis and autoimmune pancreatitis as well as the complications of these diseases. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Singh remained at Johns Hopkins to complete residency training in internal medicine. He pursued fellowship training in gastroenterology at Brigham and Women’s Hospital, and earned a master’s degree in epidemiology from the Harvard T. H. Chan School of Public Health. He then returned to Johns Hopkins, where he completed a two-year advanced endoscopy fellowship with a focus on pancreaticobiliary endoscopy. Dr. Singh has been on the faculty at Johns Hopkins since 2008, and rose to the rank of professor in 2021. His research interests include acute and chronic pancreatitis, autoimmune pancreatitis, exocrine pancreatic insufficiency, and novel methods to evaluate and treat abdominal pain. Dr. Singh is a member of the board of directors of the National Pancreas Foundation, chair of the Pancreatic Disorders Section of the American Gastroenterological Association, a councilor for the International Association of Pancreatology and a member of the inaugural medical advisory board for the Familial Chylomicronemia Syndrome Foundation. Dr. Singh is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Exocrine Pancreatic Insufficiency, Hereditary Pancreatitis, Acute Pancreatitis, Pancreatectomy, and Endoscopy.

Dr. Cunningham earned his M.D. from George Washington University and completed general surgery residency at the University of Maryland. He has completed fellowships in both oncology research and pancreatic and hepatobiliary surgery at Johns Hopkins Hospital. Throughout his career, he has been a prolific contributor and editor with over 100 contributions to a variety of medical journals, guidelines, conferences and textbooks [see Research tab]. He has also served as a Cancer Liaison Physician for the American College of Surgeons, Commission on Cancer. A member the American College of Surgeons, the Society for American Gastrointestinal & Endoscopic Surgeons, the Americas Hepato-Pancreato-Biliary Association, the International Hepato-Pancreato-Biliary Association, the Society for Surgical Oncology, the Society for Surgery of the Alimentary Tract, and the Pancreas Club, Dr. Cunningham offers world-class multidisciplinary and minimally invasive evaluation and treatment of pancreatic, biliary and liver diseases, both benign and malignant. LinkedIn https://www.linkedin.com/in/stevenccunningham. Dr. Cunningham is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Biliary Dyskinesia, Gallbladder Disease, Pancreatic Cancer, Gallbladder Removal, and Pancreaticoduodenectomy.

Dr. Hicks specializes in congenital aortic pathologies including aberrant subclavian arteries and aortic coarctation, thoracic and abdominal aortic aneurysms, complex lower extremity revascularization including lower extremity bypasses and stenting, and carotid endarterectomy. She is skilled in both open and endovascular surgery for the treatment of aortic and peripheral disease. She is also accomplished in clinical research with over 130 peer-reviewed publications and numerous textbook chapters; her research interests include clinical outcomes in aneurysm repair and lower extremity revascularization, as well as high-value care in vascular surgery. A distinguished fellow of the American Board of Surgery, Dr. Hicks is the recipient of the Department of Surgery Rothman Early Career Development Award for Surgical Research and was selected as a Visiting Scholar to the American Board of Medical Specialties for 2018-2019. She is also an appointed member of a CMS Clinical Expert Subcommittee tasked with refining peripheral vascular disease cost measures for implementation in the Quality Payment Program. LinkedIn https://www.linkedin.com/in/caitlin-hicks-b211b617/. Dr. Hicks is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. Her top areas of expertise are Carotid Artery Disease, Peripheral Artery Disease, Thoracic Aortic Aneurysm, Carotid Artery Surgery, and Aneurysm Repair.

Gastroenterologist Saowanee Ngamruengphong specializes in the endoscopic diagnosis and management of gastrointestinal malignancies, premalignant and malignant lesions in the gastrointestinal tract (e.g., early gastric cancer, Barrett's esophagus-associated neoplasia), esophageal cancer, colon polyps or early colorectal cancer, and pancreatic and biliary disease. Dr. Ngamruengphong earned a medical degree from Chulalongkorn University and completed residency training at the Texas Tech University Health Sciences Center. She undertook fellowship training in gastroenterology at the Mayo School of Graduate Medical Education and further fellowship training in therapeutic endoscopy at The Johns Hopkins Hospital. Her research interests include endoscopic resection and the management of precancerous or cancerous gastrointestinal lesions. Dr. Ngamruengphong is a member of several professional organizations, including the Thai Medical Council, the American College of Gastroenterology and the American Gastroenterological Association. Videos Endoscopic Submucosal Dissection (ESD) — Eileen’s Story Recent News Articles and Media Coverage A Rare, Stomach-Saving Endoscopic Procedure, Inside Tract (Spring 2021) Case Presentation: ESD-TAMIS, Inside Tract (Spring 2019) Innovative Approaches to Colorectal Surgery Benefit Patients, Surgery (Winter 2019) For Colorectal Polyps: Early Detection and Minimally Invasive Endoscopic Resection, Inside Tract (Winter, 2019) The Cutting Edge of Endoscopic Resection, Inside Tract (Spring, 2017) Stomach Cancer: Know Your Risks & Treatment Options, Johns Hopkins Surgery (4/26/2017). Dr. Ngamruengphong is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. Her top areas of expertise are Achalasia, Pancreatic Pseudocyst, Stomach Cancer, Endoscopy, and Gastric Bypass.

Dr. Shin specializes Barrett's esophagus, pancreatobiliary disease (pancreatic cyst, family history of pancreatic cancer), GI malignancy, and advanced endoscopy, including endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS). Dr. Shin is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Bile Duct Stricture, Endoscopy, and Pancreaticoduodenectomy.

Dr. Robert Liddell is an Assistant Professor of Radiology and Surgery and Division Chief of Interventional Radiology at the Johns Hopkins School of Medicine. His specialty is interventional radiology, with an expertise in interventional oncology and vascular and interventional radiology. Dr. Liddell received his MBBCh at the Royal College of Surgeons in Ireland. He completed his residency at Johns Hopkins University School of Medicine in Diagnostic Radiology and his fellowship in Interventional Radiology. Videos Interventional Radiology. Dr. Liddell is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Bile Duct Obstruction, Ascites, Fibrolamellar Carcinoma, Liver Embolization, and Pancreaticoduodenectomy.

Dr. Ross C. Donehower is an oncologist in the Baltimore area, caring for patients with gastrointestinal cancers. He was part of the team that developed premedications that allowed paclitaxel — a chemotherapy medication now used to treat several types of cancers — to be safely given to patients. The Virginia and D.K. Ludwig Professor in Clinical Investigation of Cancer, he serves as the director of the Hematology & Medical Oncology Fellowship Program and director of the Division of Medical Oncology at the Johns Hopkins School of Medicine. Dr. Donehower received his undergraduate degree from Hamline University and earned his M.D. from the University of Minnesota. He completed his residency at The Johns Hopkins Hospital. Dr. Donehower joined the Johns Hopkins faculty in 1980. Prior to joining Johns Hopkins, Dr. Donehower was a surgeon with the U.S. Public Health Service and a clinical associate of the medicine branch and clinical pharmacology branch at the National Cancer Institute. His research interests include gastrointestinal cancers, new anticancer drug development and pharmacology. Dr. Donehower serves on the editorial boards of numerous scholarly journals, including the International Journal of Oncology. He has been recognized by the American Society of Clinical Oncology with a 2017 Excellence in Teaching Award. He is a member of several professional organizations, including the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Donehower is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Colorectal Cancer, Neuroendocrine Tumor, Familial Colorectal Cancer, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Norman G. Nicolson, M.D., M.H.S., is an Assistant Professor of Surgery at the Johns Hopkins University School of Medicine and a surgical oncologist within the Division of HPB & Gastrointestinal Surgical Oncology. Dr. Nicolson completed his complex general surgical oncology clinical fellowship training and an NIH-funded T32 research fellowship at Johns Hopkins prior to joining the surgical faculty. Prior to this, he completed his undergraduate work at Williams College and medical degree at Northwestern University, followed by internship and residency in general surgery at Yale New Haven Hospital with a Masters in Health Sciences and research fellowship at Yale University. Dr. Nicolson specializes in treating patients with gastric cancer, peritoneal surface malignancy, appendiceal neoplasms, retroperitoneal sarcoma, gastrointestinal neuroendocrine and stromal tumors, and complex or recurrent tumors of the GI tract. He is trained in both minimally invasive and traditional open approaches to treating these cancers, utilizing laparoscopic or robotic approaches when appropriate. He emphasizes the importance of multi-disciplinary care and patient-centered decision-making, working closely with colleagues in medical and radiation oncology, gastroenterology, and radiology to provide comprehensive personalized cancer care appropriate to each individual. Dr. Nicolson's translational research focuses on computational and bioinformatics approaches to high-dimensional sequencing data from human biospecimens to better understand tumor cell biomarker heterogeneity and the importance of the tumor-draining lymph node in tumor-immune cell interactions in gastrointestinal tumors. He is a member of several academic and clinical professional societies, including the American College of Surgeons, the Association for Academic Surgery, the American Society for Clinical Oncology, the American Association for Cancer Research, and the Society of Surgical Oncology. Dr. Nicolson is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Adrenocortical Carcinoma, Adrenal Cancer, Follicular Thyroid Cancer, Pancreaticoduodenectomy, and Thyroidectomy.

Marco Dal Molin, M.D., is a surgical oncologist that specializes in hepatobiliary, pancreatic and gastrointestinal surgical oncology at the Johns Hopkins Hospital. Dr. Dal Molin earned his medical degree at the University of Verona School of Medicine in Italy, followed by a general surgery residency at the University of Verona/Pancreas Institute. He completed a second general surgery residency at the University of Maryland in Baltimore, and a fellowship in Complex General Surgical Oncology at Johns Hopkins. Dr. Dal Molin received extensive postdoctoral research training at Johns Hopkins, including an NIH-funded T32 research fellowship prior to joining the surgical faculty. He specializes in the management of patients with pancreatic cancer, pancreatic cysts, as well as cancers of the liver, biliary tree and gastrointestinal tract. He is trained in traditional open and minimally invasive techniques to treating these cancers, using both laparoscopic and robotic approaches. Dr. Dal Molin’s research focuses on the development of liquid biopsies to improve the earlier detection and management of pancreatic cancer and pancreatic cysts. Another area of focus is the development of novel immunotherapies to treat pancreatic and hepatobiliary cancers. Dr. Molin is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.